HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells.

AbstractBACKGROUND:
Oligodeoxynucleotides (ODNs) containing unmethylated cytosine-guanosine (CpG) sequence motifs constitute the immunostimulatory components of bacterial DNA which potently activate innate immunity. Administration of CpG-ODNs before the onset of experimental colitis prevents intestinal inflammation by induction of colitis-suppressing T cells.
AIMS:
To identify the interplay between innate and adaptive immune cells finally leading to protective CpG-ODN effects in intestinal inflammation.
METHODS:
Total splenic cells or purified selected cell types (CD4(+)CD62L(+) T cells alone or with B cells or dendritic cells (DCs)) from BALB/c mice were (co)-incubated in vitro with CpG-ODN for 5 days and CD4(+)CD62L(+) cells were injected intraperitoneally into C.B.-17 SCID (severe combined immunodeficiency) mice. Splenic CD4(+)CD62L(+) T cells were isolated from transgenic donor mice in which CD11c(+) DCs were depleted by diphtheria toxin administration during CpG-ODN treatment and injected into C57BL/6 Rag2(-/-) recipients. Intestinal inflammation was evaluated by histological scoring and cytokine secretion of mesenteric lymph node cells.
RESULTS:
CpG-ODN treatment of total splenic cells but not of purified CD4(+)CD62L(+) cells reduced the colitogenic potential of transferred T cells. While CpG-ODN stimulation of co-cultured CD4(+)CD62L(+) and B-cells did not alter the colitogenic potential of T cells, co-incubation of CpG-ODN-stimulated DCs and CD4(+)CD62L(+) cells reduced the colitogenic potential of the T cell population. Depletion of CD11c(+) DCs during CpG-ODN administration in vivo abolished the protective CpG-ODN effects.
CONCLUSIONS:
CpG-ODN-dependent protective effects in experimental colitis act indirectly on CD4(+)CD62L(+) T cells. While the involvement of B cells could be excluded, CD11c(+) DCs were identified as key mediators of CpG-ODN-induced protection in experimental colitis.
AuthorsClaudia Hofmann, Nadja Dunger, Nicole Grunwald, Günter J Hämmerling, Petra Hoffmann, Jürgen Schölmerich, Werner Falk, Florian Obermeier
JournalGut (Gut) Vol. 59 Issue 10 Pg. 1347-54 (Oct 2010) ISSN: 1468-3288 [Electronic] England
PMID20732920 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD19
  • CPG-oligonucleotide
  • DNA, Bacterial
  • Interferon Type I
  • Oligodeoxyribonucleotides
  • L-Selectin
Topics
  • Animals
  • Antigens, CD19 (analysis)
  • B-Lymphocyte Subsets (immunology)
  • CD4-Positive T-Lymphocytes (immunology)
  • Cells, Cultured
  • Coculture Techniques
  • Colitis (immunology, prevention & control)
  • DNA, Bacterial (immunology)
  • Dendritic Cells (immunology)
  • Disease Models, Animal
  • Interferon Type I (immunology)
  • L-Selectin (analysis)
  • Lymphocyte Transfusion
  • Mice
  • Mice, SCID
  • Mice, Transgenic
  • Oligodeoxyribonucleotides (immunology)
  • Spleen (immunology)
  • T-Lymphocyte Subsets (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: